Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trial

• Κύριοι συγγραφείς: Harbans Singh (Συγγραφέας), Babita Yadav (Συγγραφέας), Amit K. Rai (Συγγραφέας), Sumit Srivastava (Συγγραφέας), AJV Saiprasad (Συγγραφέας), Sophia Jameela (Συγγραφέας), Richa Singhal (Συγγραφέας), Sanuj Muralidharan (Συγγραφέας), Rijin Mohan (Συγγραφέας), Shikha Chaudhary (Συγγραφέας), Rakesh Rana (Συγγραφέας), Shruti Khanduri (Συγγραφέας), Bhagwan S. Sharma (Συγγραφέας), Bhogavalli Chandrasekhararao (Συγγραφέας), Narayanam Srikanth (Συγγραφέας), Kartar S. Dhiman (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Elsevier, 2023-09-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Background: Ayurveda interventions have been used for prophylaxis and care during the COVID-19 pandemic in India and have shown promising results in promoting early clinical recovery from COVID-19. Objective: To assess the efficacy and safety of Ashwagandha [Withania somnifera (L.) Dunal] tablet and...